Sarah James
Stock Analyst at Cantor Fitzgerald
(4.05)
# 1,731
Out of 4,690 analysts
501
Total ratings
55.3%
Success rate
5.4%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NPCE NeuroPace | Reiterated: Buy | $21 | $14.41 | +45.73% | 2 | Aug 17, 2026 | |
| CVRX CVRx, Inc. | Maintained: Buy | $13 → $5 | $2.95 | +69.49% | 2 | Aug 17, 2026 | |
| NYXH Nyxoah | Reiterated: Buy | $11 → $6 | $1.60 | +275.00% | 2 | Aug 17, 2026 | |
| SGRY Surgery Partners | Maintained: Buy | $33 → $18 | $13.69 | +31.48% | 10 | Aug 10, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 | $26.00 | +19.23% | 14 | Aug 6, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $15 | $3.14 | +377.71% | 12 | Aug 5, 2026 | |
| ACHC Acadia Healthcare Company | Maintained: Hold | $30 | $28.55 | +5.08% | 17 | Jul 29, 2026 | |
| TDOC Teladoc Health | Maintained: Buy | $10 | $6.50 | +53.85% | 8 | Jul 29, 2026 | |
| CNC Centene | Reiterated: Buy | $75 | $64.75 | +15.83% | 58 | Jul 28, 2026 | |
| UHS Universal Health Services | Reiterated: Hold | $194 | $171.66 | +13.01% | 37 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $209 | $200.00 | +4.50% | 42 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 | $266.80 | -8.17% | 29 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $525 | $417.82 | +25.65% | 35 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $110 | $93.06 | +18.20% | 23 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $201 → $300 | $385.54 | -22.19% | 39 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 → $450 | $394.43 | +14.09% | 29 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 | $1.59 | +88.68% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $0.3975 | +654.72% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $340 | $278.88 | +21.92% | 28 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.8296 | +743.78% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $4.50 | +77.78% | 1 | Feb 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $440 | $392.95 | +11.97% | 45 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $28 | $29.11 | n/a | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $10.86 | n/a | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $5 | $13.32 | n/a | 3 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $128 → $103 | $180.68 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $57 | $37.96 | n/a | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $56 → $76 | $120.85 | n/a | 13 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $0.52 | n/a | 1 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 → $80 | $89.52 | n/a | 7 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $3 | $2.93 | n/a | 12 | Aug 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $290 | $372.60 | n/a | 1 | Oct 19, 2017 |
NeuroPace
Aug 17, 2026
Reiterated: Buy
Price Target: $21
Current: $14.41
Upside: +45.73%
CVRx, Inc.
Aug 17, 2026
Maintained: Buy
Price Target: $13 → $5
Current: $2.95
Upside: +69.49%
Nyxoah
Aug 17, 2026
Reiterated: Buy
Price Target: $11 → $6
Current: $1.60
Upside: +275.00%
Surgery Partners
Aug 10, 2026
Maintained: Buy
Price Target: $33 → $18
Current: $13.69
Upside: +31.48%
Progyny
Aug 6, 2026
Reiterated: Buy
Price Target: $31
Current: $26.00
Upside: +19.23%
LifeMD
Aug 5, 2026
Reiterated: Buy
Price Target: $15
Current: $3.14
Upside: +377.71%
Acadia Healthcare Company
Jul 29, 2026
Maintained: Hold
Price Target: $30
Current: $28.55
Upside: +5.08%
Teladoc Health
Jul 29, 2026
Maintained: Buy
Price Target: $10
Current: $6.50
Upside: +53.85%
Centene
Jul 28, 2026
Reiterated: Buy
Price Target: $75
Current: $64.75
Upside: +15.83%
Universal Health Services
Jul 28, 2026
Reiterated: Hold
Price Target: $194
Current: $171.66
Upside: +13.01%
Jul 23, 2026
Maintained: Hold
Price Target: $209
Current: $200.00
Upside: +4.50%
Jul 23, 2026
Maintained: Buy
Price Target: $245
Current: $266.80
Upside: -8.17%
Jul 14, 2026
Maintained: Buy
Price Target: $525
Current: $417.82
Upside: +25.65%
Jul 7, 2026
Maintained: Buy
Price Target: $95 → $110
Current: $93.06
Upside: +18.20%
Jul 7, 2026
Maintained: Hold
Price Target: $201 → $300
Current: $385.54
Upside: -22.19%
Jul 7, 2026
Maintained: Buy
Price Target: $400 → $450
Current: $394.43
Upside: +14.09%
May 8, 2026
Maintained: Hold
Price Target: $3
Current: $1.59
Upside: +88.68%
May 8, 2026
Maintained: Buy
Price Target: $3
Current: $0.3975
Upside: +654.72%
Apr 30, 2026
Reiterated: Buy
Price Target: $365 → $340
Current: $278.88
Upside: +21.92%
Apr 20, 2026
Maintained: Buy
Price Target: $7
Current: $0.8296
Upside: +743.78%
Feb 15, 2026
Maintained: Buy
Price Target: $8
Current: $4.50
Upside: +77.78%
Jan 28, 2026
Maintained: Buy
Price Target: $440
Current: $392.95
Upside: +11.97%
Jun 13, 2025
Reiterated: Buy
Price Target: $33 → $28
Current: $29.11
Upside: n/a
Sep 15, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $10.86
Upside: n/a
Aug 19, 2022
Maintained: Buy
Price Target: $7 → $5
Current: $13.32
Upside: n/a
Aug 16, 2022
Maintained: Hold
Price Target: $128 → $103
Current: $180.68
Upside: n/a
Aug 5, 2022
Maintained: Hold
Price Target: $50 → $57
Current: $37.96
Upside: n/a
Nov 23, 2020
Upgraded: Buy
Price Target: $56 → $76
Current: $120.85
Upside: n/a
Jun 15, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $0.52
Upside: n/a
Nov 11, 2019
Maintained: Buy
Price Target: $96 → $80
Current: $89.52
Upside: n/a
Aug 7, 2019
Maintained: Sell
Price Target: $4 → $3
Current: $2.93
Upside: n/a
Oct 19, 2017
Reiterated: Hold
Price Target: $290
Current: $372.60
Upside: n/a